India's Symbiotec Pharmalab rises after muted debut, valued at $779 million
01/09/2026 07:57
BUZZ-India's Symbiotec Pharmalab rises after muted debut, valued at $779 million ** Shares of India's Symbiotec Pharmalab SYMI.NS rise 18.8% to 1,174 rupees in trading debut, after listing at IPO issue price of 988 rupees
** Co valued at 73.89 billion rupees ($778.98 million)
** Drugmaker's 17.57-billion-rupee IPO comprised fresh issue of shares worth up to 1.50 billion rupees and offer for sale of shares worth up to 16.07 billion rupees
** IPO was subscribed 71.26 times, led by institutional buyers, who bid 172 times the shares set aside for them
** Trading volume at 22.41 million shares
($1 = 94.8550 Indian rupees)
(Reporting by Payel Das in Bengaluru)
Recent news on Symbiotec Pharmalab
See all newsIndia's Symbiotec Pharmalab rises on US drug distribution deal
Brief: Symbiotec Pharmalab Unit Enters Into Strategic Commercialization Agreement
Brief: Symbiotec Pharmalab Receives U.S. FDA Eir For Pithampur Facility With Vai Status
India's Symbiotec Pharmalab declines after Q1 profit fall
India's Symbiotec Pharmalab rises after muted debut, valued at $779 million